Joe Bernardo

Joe Bernardo has been named chairman of the board of SeraCare Life Sciences. Bernardo is also an operating partner at Linden Capital Partners, the equity investors behind SeraCare. Prior to these roles, he served as president of the next-generation sequencing and oncology division at Thermo Fisher Scientific. He has also worked for Siemens Healthcare, where he was senior vice president of the central lab business unit, and Abbott Laboratories.


Giulia Kennedy, Jessica Meng

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.